ARCUS BIOSCIENCES INC's ticker is RCUS and the CUSIP is 03969F109. A total of 182 filers reported holding ARCUS BIOSCIENCES INC in Q1 2023. The put-call ratio across all filers is 0.75 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $284,148 | -18.2% | 15,830 | -7.4% | 0.00% | 0.0% |
| Q2 2023 | $347,300 | -32.5% | 17,100 | -39.4% | 0.00% | 0.0% |
| Q1 2023 | $514,457 | +478.5% | 28,205 | +555.9% | 0.00% | – |
| Q4 2022 | $88,924 | -69.0% | 4,300 | -59.2% | 0.00% | – |
| Q2 2021 | $287,000 | -8.6% | 10,540 | -5.9% | 0.00% | -100.0% |
| Q1 2021 | $314,000 | +57.0% | 11,198 | +38.2% | 0.00% | – |
| Q2 2020 | $200,000 | -3.4% | 8,100 | -60.7% | 0.00% | – |
| Q4 2019 | $207,000 | +6.2% | 20,600 | -3.4% | 0.00% | – |
| Q3 2019 | $195,000 | +52.3% | 21,315 | +32.9% | 0.00% | – |
| Q2 2019 | $128,000 | – | 16,037 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Invus Financial Advisors, LLC | 1,612,077 | $50,877,000 | 22.64% |
| Octagon Capital Advisors LP | 2,489,974 | $78,584,000 | 16.99% |
| Decheng Capital Management III (Cayman), LLC | 869,790 | $27,451,000 | 8.41% |
| BVF INC/IL | 3,960,948 | $125,008,000 | 5.00% |
| PFM Health Sciences, LP | 3,431,010 | $108,283,000 | 4.05% |
| EcoR1 Capital, LLC | 3,265,101 | $103,047,000 | 3.22% |
| Alphabet Inc. | 2,563,441 | $80,902,000 | 2.62% |
| Boxer Capital, LLC | 1,432,200 | $45,200,000 | 2.32% |
| SECTORAL ASSET MANAGEMENT INC | 338,480 | $10,682,000 | 1.90% |
| PARK CIRCLE Co | 64,000 | $2,020,000 | 1.68% |